C2 single-point sampling to evaluate cyclosporine exposure in long-term renal transplant recipients

By Citterio F.   Scata M.C.   Borzi M.T.   Pozzetto U.   Castagneto M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3133-3136

Elsevier

Access to resources Recommend Favorite

Cyclosporine blood concentration at 2 hours (C 2 ) from drug ingestion as the best single indicator of adequate cyclosporine immunosuppression in renal allograft recipients- a four-year follow-up

By Baczkowska T.   Serafinowicz A.   Kukula K.   Nowacka-Cieciura E.   Cieciura T.   Deborska D.   Galazka Z.   Rowinski W.   Szmidt J.   Durlik M.   Lao M.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 556-557

Elsevier

Access to resources Recommend Favorite

Cyclosporine lymphocyte level and lymphocyte count: new guidelines for tailoring immunosuppressive therapy

By Barbari A.   Stephan A.   Masri M.   Mourad N.   Kamel G.   Kilani H.   Karam A.   Daya I.A.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2742-2744

Elsevier

Access to resources Recommend Favorite

Cyclosporine A: peak or trough level monitoring in renal transplant recipients?

By Wacke R.   Drewelow B.   Kundt G.   Hehl E.-M.   Bast R.   Seiter H.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3122-3123

Elsevier

Access to resources Recommend Favorite

Three-hour postdose cyclosporine level monitoring: less rejection and more nephrotoxicity?

By Domnguez J.   Tomic A.   Norambuena R.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3120-3121

Elsevier

Access to resources Recommend Favorite